Empagliflozin Attenuates Ferroptosis in Acute Myocardial Infarction via the AMPK/NRF2/SLC7A11 Signaling Pathway.
Investigating whether empagliflozin suppresses ferroptosis in acute myocardial infarction via the AMP-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (NRF2)/solute carrier family 7 member 11 (SLC7A11) pathway found it suppressed ferroptosis and ameliorated cellular injury in H/R-injured card...